The EU’s drug watchdog said Friday that a review of AstraZeneca’s COVID-19 vaccine found its benefits increase with age and still outweigh the risks for adults despite links to blood clots.
The EU’s drug watchdog said Friday that a review of AstraZeneca’s COVID-19 vaccine found its benefits increase with age and still outweigh the risks for adults despite links to blood clots.
